218 related articles for article (PubMed ID: 32572522)
21. Revisiting the Utility of Granulocyte Colony-Stimulating Factor Post-Autologous Hematopoietic Stem Cell Transplantation for Outpatient-Based Transplantations.
Portuguese AJ; Holmberg L; Hill GR; Lee SJ; Green DJ; Mielcarek M; Gooley T; Yeh AC
Transplant Cell Ther; 2023 Nov; 29(11):696.e1-696.e7. PubMed ID: 37634844
[TBL] [Abstract][Full Text] [Related]
22. Factors that influence collection and engraftment of autologous peripheral-blood stem cells.
Bensinger W; Appelbaum F; Rowley S; Storb R; Sanders J; Lilleby K; Gooley T; Demirer T; Schiffman K; Weaver C
J Clin Oncol; 1995 Oct; 13(10):2547-55. PubMed ID: 7595706
[TBL] [Abstract][Full Text] [Related]
23. Predictive factors for a single successful cytapheresis session during the first mobilisation.
Gac AC; Parienti JJ; Chantepie S; Cheze S; Johnson-Ansah H; Benabed K; Macro M; Lefevre V; Batho A; Fruchart C; Reman O
Leuk Res; 2014 Sep; 38(9):1020-4. PubMed ID: 25073661
[TBL] [Abstract][Full Text] [Related]
24. CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients.
Hicks C; Isaacs A; Wong R; Chong BH
Ann Hematol; 2011 May; 90(5):547-55. PubMed ID: 20957366
[TBL] [Abstract][Full Text] [Related]
25. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment.
Koç ON; Gerson SL; Phillips GL; Cooper BW; Kutteh L; Van Zant G; Reece DE; Fox RM; Schupp JE; Tainer N; Lazarus HM
Bone Marrow Transplant; 1998 Feb; 21(4):337-43. PubMed ID: 9509966
[TBL] [Abstract][Full Text] [Related]
26. Re-infused autologous graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation.
Porrata LF; Gastineau DA; Padley D; Bundy K; Markovic SN
Leuk Lymphoma; 2003 Jun; 44(6):997-1000. PubMed ID: 12854901
[TBL] [Abstract][Full Text] [Related]
27. Second stem cell transplantation for treatment of relapsed/refractory multiple myeloma after first autologous stem cell transplant: A 15-year retrospective institutional analysis.
Yadav N; Mirgh SP; Aggarwal M; Agrawal N; Mehta P; Khushoo V; Kapoor J; Bhatia N; Agrawal P; Ahmed R; Bhurani D
Indian J Cancer; 2023; 60(3):316-324. PubMed ID: 37787191
[TBL] [Abstract][Full Text] [Related]
28. Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation.
Chakraborty R; Muchtar E; Kumar SK; Buadi FK; Dingli D; Dispenzieri A; Hayman SR; Hogan WJ; Kapoor P; Lacy MQ; Leung N; Gertz MA
Bone Marrow Transplant; 2018 Feb; 53(2):155-161. PubMed ID: 29131152
[TBL] [Abstract][Full Text] [Related]
29. Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height loss.
Maclean PS; Parker AN; McQuaker IG; Clark AD; Farrell E; Douglas KW
Bone Marrow Transplant; 2007 Oct; 40(7):665-9. PubMed ID: 17646841
[TBL] [Abstract][Full Text] [Related]
30. Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery.
Remes K; Matinlauri I; Grenman S; Itälä M; Kauppila M; Pelliniemi TT; Salminen E; Vanharanta R; Rajamäki A
J Hematother; 1997 Feb; 6(1):13-9. PubMed ID: 9112214
[TBL] [Abstract][Full Text] [Related]
31. Factors affecting stem cell mobilization for autologous hematopoietic stem cell transplantation.
Ozkurt ZN; Yegin ZA; Suyani E; Aki SZ; Acar K; Yagci M; Sucak GT
J Clin Apher; 2010; 25(5):280-6. PubMed ID: 20623783
[TBL] [Abstract][Full Text] [Related]
32. Peripheral blood progenitor cell harvesting in multiple myeloma and malignant lymphoma.
Scott MA; Ager S; Apperley JF; Jestice HK; Bloxham DM; Boraks P; Mahendra P; Marcus RE
Leuk Lymphoma; 1995 Nov; 19(5-6):479-84. PubMed ID: 8590850
[TBL] [Abstract][Full Text] [Related]
33. Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution.
Michallet M; Philip T; Philip I; Godinot H; Sebban C; Salles G; Thiebaut A; Biron P; Lopez F; Mazars P; Roubi N; Leemhuis T; Hanania E; Reading C; Fine G; Atkinson K; Juttner C; Coiffier B; Fière D; Archimbaud E
Exp Hematol; 2000 Jul; 28(7):858-70. PubMed ID: 10907648
[TBL] [Abstract][Full Text] [Related]
34. Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study.
Antlanger M; Dust T; Reiter T; Böhm A; Lamm WW; Gornicec M; Willenbacher E; Nachbaur D; Weger R; Rabitsch W; Rasoul-Rockenschaub S; Worel N; Lechner D; Greinix H; Keil F; Gisslinger H; Agis H; Krauth MT
BMC Cancer; 2018 Oct; 18(1):1008. PubMed ID: 30342509
[TBL] [Abstract][Full Text] [Related]
35. Peripheral Stem Cell Apheresis is Feasible Post
Kraal KCJM; Timmerman I; Kansen HM; van den Bos C; Zsiros J; van den Berg H; Somers S; Braakman E; Peek AML; van Noesel MM; van der Schoot CE; Fiocco M; Caron HN; Voermans C; Tytgat GAM
Clin Cancer Res; 2019 Feb; 25(3):1012-1021. PubMed ID: 30314967
[TBL] [Abstract][Full Text] [Related]
36. Single-dose etoposide is an effective and safe protocol for stem cell mobilization in patients with multiple myeloma.
Park Y; Kim DS; Jeon MJ; Lee BH; Yu ES; Kang KW; Lee SR; Sung HJ; Nam MH; Yoon SY; Choi CW; Kang ES; Cho D; Kim K; Kim BS; Kim DW; Kim SJ
J Clin Apher; 2019 Oct; 34(5):579-588. PubMed ID: 31283042
[TBL] [Abstract][Full Text] [Related]
37. Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipients.
Lutfi F; Skelton Iv WP; Wang Y; Rosenau E; Farhadfar N; Murthy H; Cogle CR; Brown R; Hiemenz J; Wingard JR; Norkin M
Hematol Oncol Stem Cell Ther; 2020 Mar; 13(1):23-31. PubMed ID: 31629722
[TBL] [Abstract][Full Text] [Related]
38. CD34(+) cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation.
Lanza F; Campioni D; Moretti S; Dominici M; Punturieri M; Focarile E; Pauli S; Dabusti M; Tieghi A; Bacilieri M; Scapoli C; De Angeli C; Galluccio L; Castoldi G
Exp Hematol; 2001 Dec; 29(12):1484-93. PubMed ID: 11750108
[TBL] [Abstract][Full Text] [Related]
39. High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation.
Ketterer N; Salles G; Raba M; Espinouse D; Sonet A; Tremisi P; Dumontet C; Moullet I; Eljaafari-Corbin A; Neidhardt-Berard EM; Bouafia F; Coiffier B
Blood; 1998 May; 91(9):3148-55. PubMed ID: 9558369
[TBL] [Abstract][Full Text] [Related]
40. The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma.
Jaglowski SM; Ruppert AS; Hofmeister CC; Elder P; Blum W; Klisovic R; Vasu S; Penza S; Efebera YA; Benson DM; Devine SM; Andritsos LA
Bone Marrow Transplant; 2014 Oct; 49(10):1323-9. PubMed ID: 25068419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
